Signal Encoding And Decoding In Multiplexed Biochemical Assays

Patent No. US12168797 (titled "Signal Encoding And Decoding In Multiplexed Biochemical Assays") was filed by California Institute Of Technology on Jul 13, 2023.

What is this patent about?

’797 is related to the field of multiplexed analyte detection , specifically improving the throughput of assays that identify multiple targets in a single sample. Traditional multiplexed assays rely on spectrally resolved fluorescence or spatially resolved signals, which can be complex and expensive. This patent addresses the need for simpler, more cost-effective methods for detecting multiple analytes simultaneously in a single solution, without requiring immobilization, separation, or complex analysis techniques like mass spectrometry or melting curve analysis.

The underlying idea behind ’797 is to encode each analyte with a unique combination of signal characteristics , such as intensity and wavelength, such that the cumulative signal from multiple analytes can be decoded to determine the presence or absence of each individual analyte. This is achieved by assigning specific intensity values at different wavelengths to each analyte, creating a coding scheme that allows for unambiguous detection even when multiple analytes are present in the same sample. The key inventive insight is to leverage multiple components of a signal to increase the number of detectable analytes beyond the number of spectrally resolvable probes.

The claims of ’797 focus on a system for multiplexed analyte detection that includes a sample chamber, a multi-channel detector, and a processor-controlled analyzer. The multi-channel detector measures electromagnetic signals at multiple wavelengths, corresponding to different fluorophores. The processor then applies a decoding matrix to the cumulative signal to determine the presence or absence of each analyte. The claims also cover a reaction mixture comprising a plurality of non-immobilized hybridization probes, wherein at least one of the probes is conjugated to two fluorophores that emit light at different wavelengths when excited by a light source.

In practice, the invention works by first encoding each target analyte with a specific code consisting of a combination of signal intensities at different wavelengths. When a sample containing multiple analytes is analyzed, the resulting signal is a cumulative measurement of the intensities at each wavelength. The decoding matrix then translates this cumulative measurement back into the presence or absence of each individual analyte. This approach allows for a higher degree of multiplexing than traditional methods, as it utilizes the full coding capacity of the available signal components.

The invention differentiates itself from prior approaches by enabling high-throughput multiplexing without the need for complex sample preparation or analysis steps . Unlike methods that rely on spatial separation or sequential processing, this invention allows for simultaneous detection in a single solution. Furthermore, the use of a decoding matrix and the ability to eliminate degeneracy in the coding scheme ensures accurate and unambiguous detection of multiple analytes, even in complex samples. The system can be implemented using standard laboratory equipment, making it accessible and cost-effective.

How does this patent fit in bigger picture?

Technical landscape at the time

In the early 2010s when ’797 was filed, multiplexed reactions at a time when X was typically implemented using spectrally resolved fluorescence or chemiluminescence, spatially resolved signals, temporally resolved signals, or combinations thereof. There was a need for multiplexed reactions that can be carried out in a single solution.

Novelty and Inventive Step

The examiner approved the application because, while the claims recite judicial exceptions, the combination of experimental limitations in addition to the judicial exceptions are not routine and conventional in the prior art. The claims are free of the prior art because the prior art does not teach experimentally decoding electromagnetic signals to determine the presence and absence patterns of analytes using the equation and values input into the equation recited in the claims.

Claims

This patent contains 30 claims, with independent claims 1, 19, and 22. The independent claims are directed to a system and a reaction mixture for detecting the presence or absence of analytes using fluorophores and a decoding matrix. The dependent claims generally elaborate on and refine the elements and configurations described in the independent claims.

Key Claim Terms New

Definitions of key terms used in the patent claims.

Term (Source)Support for SpecificationInterpretation
Analyte-specific reagent mixtures
(Claim 1)
“Generally, a reagent will have an analyte-specific component and a component that generates a signal in the presence of the analyte. In some cases, these reagents are referred to as probes. The probes may be hybridization probes. The hybridization probes may be an oligonucleotide probe attached to a fluorophore and a quencher (e.g., a TAQMAN probe).”Reagents that are specific to particular analytes and that generate a signal in the presence of those analytes. The reagents include analyte-specific hybridization probes and multiple fluorophores.
Cumulative signal data
(Claim 19)
“When at least two components of a signal are utilized, a cumulative measurement of the at least two components may be obtained for a single sample volume. For example in the coding scheme described in Table 5, the presence of each analyte results in a particular intensity (one component of the signal) in each of the four colors (a second component of a signal). The combination of these constituent signals leads to a cumulative signal that may be measured by measuring an intensity at each wavelength or range of wavelengths.”Data obtained from a digital PCR instrument, comprising electromagnetic signals at different wavelengths generated by fluorescently labeled polynucleotide analytes.
Decoding matrix
(Claim 1, Claim 19)
“The combination of these constituent signals leads to a cumulative signal that may be measured by measuring an intensity at each wavelength or range of wavelengths. The corresponding coding scheme or decoding matrix may then be used to convert the cumulative measurement into a determination of the presence or absence of an analyte.”A matrix that is applied to the cumulative signal to determine the presence or absence of analytes based on the first and second values associated with each analyte in the coding scheme.
Hybridization probes
(Claim 22)
“The hybridization probes may be an oligonucleotide probe attached to a fluorophore and a quencher (e.g., a TAQMAN probe). The sequence of the oligonucleotide probe is designed to be complementary to a polynucleotide sequence present in an analyte, and therefore capable of hybridizing to the polynucleotide sequence present in the analyte.”Probes that hybridize to a polynucleotide sequence present in an analyte.
Non-immobilized polynucleotide analytes
(Claim 22)
“The methods and compositions presented in this disclosure may be used in solution phase assays, without the need for particles (such as beads) or a solid support.”Polynucleotide analytes that are not attached to a solid support.

Patent Family

Patent Family

File Wrapper

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

US12168797

CALIFORNIA INSTITUTE OF TECHNOLOGY
Application Number
US18352112
Filing Date
Jul 13, 2023
Status
Granted
Expiry Date
Feb 1, 2033
External Links
Slate, USPTO, Google Patents